对奥密克戎BA.4-BA.5二价加强针的抗体反应 - Suppr

Suppr

超能文献

Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.

作者信息

Wang Qian, Bowen Anthony, Valdez Riccardo, Gherasim Carmen, Gordon Aubree, Liu Lihong, Ho David D

机构信息

Columbia University Vagelos College of Physicians and Surgeons, New York, NY.

University of Michigan, Ann Arbor, MI

出版信息

N Engl J Med. 2023 Feb 9;388(6):567-569. doi: 10.1056/NEJMc2213907. Epub 2023 Jan 11.

DOI:10.1056/NEJMc2213907

PMID:36630643

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9847504/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2659/9847504/dbd0bc15c7ff/NEJMc2213907_f1.jpg

相似文献

Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.对奥密克戎BA.4-BA.5二价加强针的抗体反应

N Engl J Med. 2023 Feb 9;388(6):567-569. doi: 10.1056/NEJMc2213907. Epub 2023 Jan 11.

Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.用二价疫苗中和BA.4-BA.5、BA.4.6、BA.2.75.2、BQ.1.1和XBB.1

N Engl J Med. 2023 Mar 2;388(9):854-857. doi: 10.1056/NEJMc2214916. Epub 2023 Jan 25.

SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.养老院居民接种二价 COVID-19 疫苗后对原始 SARS-CoV-2 株和奥密克戎 BA.1 和 BA.4/BA.5 变异株的 SARS-CoV-2 抗体反应 - 俄亥俄州和罗得岛，2022 年 9 月至 11 月。

MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):100-106. doi: 10.15585/mmwr.mm7204a4.

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.BA.5二价mRNA疫苗加强针的免疫原性。

N Engl J Med. 2023 Feb 9;388(6):565-567. doi: 10.1056/NEJMc2213948. Epub 2023 Jan 11.

Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.先前感染和未感染个体接种奥密克戎二价加强针后针对原始 SARS-CoV-2 和奥密克戎 BA.5 的中和抗体和 T 细胞应答。

J Med Virol. 2023 Aug;95(8):e28989. doi: 10.1002/jmv.28989.

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.二价 SARS-CoV-2 mRNA 疫苗提高中和广度并预防小鼠感染奥密克戎变异株 BA.5。

Nat Med. 2023 Jan;29(1):247-257. doi: 10.1038/s41591-022-02092-8. Epub 2022 Oct 20.

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.奥密克戎变异株对疫苗加强后免疫血清的中和敏感性低于其他 SARS-CoV-2 变异株。

Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440.

Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.含奥密克戎变异株二价疫苗加强接种后 3 个月的抗体持久性对 COVID-19 的影响。

Nat Commun. 2023 Aug 23;14(1):5125. doi: 10.1038/s41467-023-38892-w.

Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.暴露于 BA.4/5 蛋白可导致疫苗接种者体内对奥密克戎 BA.1、BA.2、BA.2.12.1 和 BA.4/5 的中和作用。

Sci Immunol. 2022 Dec 23;7(78):eade9888. doi: 10.1126/sciimmunol.ade9888.

A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.含有 D614G 和 BA.1 刺突三聚体蛋白的二价疫苗或 BA.1 刺突三聚体蛋白加强针可产生广泛的中和免疫。

J Med Virol. 2022 Sep;94(9):4287-4293. doi: 10.1002/jmv.27885. Epub 2022 Jun 2.

引用本文的文献

Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial.雾化腺病毒载体新冠疫苗和肌肉注射mRNA疫苗二价加强针的安全性和免疫原性：一项随机开放标签临床试验。

Nat Commun. 2025 Aug 7;16(1):7281. doi: 10.1038/s41467-025-62698-7.

The immunological impact of revaccination in a hybrid-immune world.在混合免疫的世界中再次接种疫苗的免疫学影响。

Front Immunol. 2025 Jun 9;16:1588259. doi: 10.3389/fimmu.2025.1588259. eCollection 2025.

Differential patterns of cross-protection against antigenically distinct variants in small animal models of SARS-CoV-2 infection.在新冠病毒（SARS-CoV-2）感染的小动物模型中，针对抗原性不同变体的交叉保护差异模式。

Npj Viruses. 2025 Jun 4;3(1):49. doi: 10.1038/s44298-025-00125-w.

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination.免疫印记和疫苗接种间隔决定了对单价XBB.1.5新冠疫苗接种的抗体反应。

Commun Med (Lond). 2025 May 17;5(1):182. doi: 10.1038/s43856-025-00898-4.

Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株特异性初免-加强和初免-刺突蛋白疫苗接种的全身和黏膜抗体反应：小鼠模型中肌肉注射和鼻内二价疫苗接种的比较

Vaccines (Basel). 2025 Mar 25;13(4):351. doi: 10.3390/vaccines13040351.

Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination.二价mRNA新冠加强疫苗接种后，不同CD4水平的HIV感染者的免疫原性差异。

PLoS One. 2025 Apr 29;20(4):e0317940. doi: 10.1371/journal.pone.0317940. eCollection 2025.

Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses.与原始新冠病毒刺突疫苗相比，奥密克戎毒株对潜在人畜共患冠状病毒的交叉保护潜力降低。

Npj Viruses. 2024 Nov 21;2(1):58. doi: 10.1038/s44298-024-00067-9.

Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV.HIV感染者对SARS-CoV-2奥密克戎BA.4/5 mRNA加强针的长期免疫反应。

Commun Med (Lond). 2025 Mar 27;5(1):92. doi: 10.1038/s43856-025-00799-6.

The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells.XBB.1.5 mRNA加强疫苗不会显著增加XBB.1.5单反应性T细胞的百分比。

Front Immunol. 2025 Mar 12;16:1513175. doi: 10.3389/fimmu.2025.1513175. eCollection 2025.

Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections.接种疫苗后感染后的循环中和抗体与SARS-CoV-2变体复制

JCI Insight. 2025 Mar 10;10(5):e185953. doi: 10.1172/jci.insight.185953.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验